JG
AMRX icon

Jain Global’s Amneal Pharmaceuticals AMRX Stock Holding History

Jain Global’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,060,916
Closed -$13.4M – 1185
2025
Q4 		$13.4M Buy
1,060,916
+499,255
+89% +$5.71M 0.06% 282
2025
Q3 		$5.62M Sell
561,661
-14,144
-2% -$127K 0.03% 332
2025
Q2 		$4.66M Buy
575,805
+517,625
+890% +$3.9M 0.04% 352
2025
Q1 		$488K Buy
+58,180
New +$486K 0.01% 556

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jain Global's AMRX Position: Q1 2026 in Review

Jain Global sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 1,060,916 shares — an estimated $13.4M sold.

Jain Global first reported a position in AMRX in Q1 2025 and held it in 4 quarters. The position peaked at $13.4M in Q4 2025. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Jain Global reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 1,060,916 Amneal Pharmaceuticals shares in Q1 2026, an estimated $13.4M.
  • Jain Global first reported a position in Amneal Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Jain Global's Amneal Pharmaceuticals position peaked at $13.4M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.